British Journal of Anaesthesia, Vol 82, Issue 2 280-282, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia
M. Bay-Nielsen, B. Klarskov, K. Bech, J. Andersen and H. Kehlet
We have compared the anaesthetic and analgesic efficacy of levobupivacaine
with that of racemic bupivacaine in 66 male patients undergoing ambulatory
primary inguinal herniorrhaphy. Patients were allocated randomly in a
double-blind manner to local infiltration anaesthesia (0.25% w/v 50 ml)
with either racemic bupivacaine (n = 33) or levobupivacaine (n = 33).
Scores for intraoperative pain and satisfaction with anaesthesia were
recorded, together with perception of postoperative pain and need for
supplementary postoperative analgesic medications in the first 48 h after
operation. Intraoperative satisfaction with the infiltration anaesthesia
was similar, with median scores of 77 (levobupivacaine) and 80
(bupivacaine) (VAS; 100 mm = extremely satisfied). Time averaged
postoperative pain scores (48 h) were 8 (levobupivacaine) and 10
(bupivacaine) in the supine position, 13 (levobupivacaine) and 12
(bupivacaine) while rising from the supine position to sitting, and 9
(levobupivacaine) and 13 (bupivacaine) while walking (VAS; 100 mm = worst
pain imaginable) (ns). There was no difference in the use of peroral
postoperative analgesics between the two groups. We conclude that racemic
bupivacaine and its S-enantiomer levobupivacaine had similar efficacy when
used as local infiltration anaesthesia in inguinal herniorrhaphy.
SHORT COMMUNICATIONS
Levobupivacaine vs bupivacaine as infiltration anaesthesia in inguinal herniorrhaphy
Department of Surgical Gastroenterology, Copenhagen University Hospital, Hvidovre, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Demiraran, O. Ozturk, E. Guclu, A. Iskender, M. H. Ergin, and A. Tokmak Vasoconstriction and Analgesic Efficacy of Locally Infiltrated Levobupivacaine for Nasal Surgery Anesth. Analg., March 1, 2008; 106(3): 1008 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Rosenberg and S. A. Schug Levobupivacaine base and levobupivacaine hydrochloride Br. J. Anaesth., April 1, 2005; 94(4): 544 - 544. [Full Text] [PDF] |
||||
![]() |
C. Glaser, P. Marhofer, G. Zimpfer, M. T. Heinz, C. Sitzwohl, S. Kapral, and I. Schindler Levobupivacaine Versus Racemic Bupivacaine for Spinal Anesthesia Anesth. Analg., January 1, 2002; 94(1): 194 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Whiteside and J. A. W. Wildsmith Developments in local anaesthetic drugs Br. J. Anaesth., July 1, 2001; 87(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H-T Chang, L. A. Ladd, K. A. Wilson, L. Gelgor, and L. E. Mather Tolerability of Large-Dose Intravenous Levobupivacaine in Sheep Anesth. Analg., September 1, 2000; 91(3): 671 - 679. [Abstract] [Full Text] [PDF] |
||||

